• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Q1 2014 Investtor Conference Call Presentation Charts
 

Q1 2014 Investtor Conference Call Presentation Charts

on

  • 148 views

Presentation Charts for Q1 2014 Investtor Conference Call on April 28, 2014

Presentation Charts for Q1 2014 Investtor Conference Call on April 28, 2014

Statistics

Views

Total Views
148
Views on SlideShare
145
Embed Views
3

Actions

Likes
0
Downloads
2
Comments
0

2 Embeds 3

http://www.linkedin.com 2
https://www.linkedin.com 1

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Q1 2014 Investtor Conference Call Presentation Charts Q1 2014 Investtor Conference Call Presentation Charts Presentation Transcript

    • Investor Conference Call Q1 2014 Results April 28, 2014 / Marijn Dekkers, CEO • Q1 2014 Investor Conference Call • Marijn DekkersPage 1
    • Disclaimer This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. • Q1 2014 Investor Conference Call • Marijn DekkersPage 2
    • Page 3 Q1 2014 – Very Successful Start to the Year  Encouraging business development in all subgroups  Strong growth for recently launched pharma products  Early start to the season in Europe for CropScience  MaterialScience with considerable earnings improvement  Operational strength compensated currency headwind  Closing of Algeta acquisition  Full-year Group Guidance 2014 maintained • Q1 2014 Investor Conference Call • Marijn Dekkers
    • Page 4 EBIT in € million +18% 2,096 1,771 Sales in € million % currency & portfolio adj. +8% 10,55510,266 EBITDA adjusted* in € million +12% 2,738 2,453 Core EPS in € +15% 1.95 1.70 *before special items Q1’14Q1’13 Q1’14Q1’13 Q1’14Q1’13 Q1’14Q1’13 Q1 2014 – Strong Sales and Earnings Growth Despite Significant Currency Headwind • Q1 2014 Investor Conference Call • Marijn Dekkers
    • Q1 2014 – Regional Performance: Growth Led by Emerging Markets Page 5 Africa & Middle East Eastern Europe Emerging Markets Emerging Markets¹ +11% Others² +13% USA +2% Western Europe +9% Group Sales by Region Group €10,555m; +9% ~900 +12% ~1,400 +9% ~400 +10% ~800 +16% ¹ Emerging economies include: Latin America, Asia w/o Japan, Australia, New Zealand, Africa and Middle East incl. Turkey, Eastern Europe ² Others = Japan, Australia, New Zealand, Canada ³ Emerging Asia = Asia w/o Japan, Australia, New Zealand In € million, ∆% yoy Fx adjusted 34% 11%34% 21% Latin America Emerging Asia³ • Q1 2014 Investor Conference Call • Marijn Dekkers
    • Q1 2014 – Cash Flow And Net Debt Development Page 6 +€2.4bn 9.1GCF oFCF 2,048 Invest- ments 357 (194) ∆ y-o-y +13% [Q1’13:(38)] NCF 163 -50% -2% Dec 31, 2013 March 31, 2014 6.7 Cash Flow Net Debt Development Cash Flow in € million, Net Debt in € billion • Q1 2014 Investor Conference Call • Marijn Dekkers
    • Q1 2014 – HealthCare: Recently Launched Products Drive Growth Page 7 *before special items Sales Earnings Pharma +9% (+15%) Consumer Health -5% (+1%) 36% HealthCare €4,572m; +3% (+9%) 2,7821,790 Price 0% Volume +9% Fx -7% Portfolio +1% In € million, ∆% yoy, () = Fx & portf. adjusted Q1‘13 Q1‘14 Q1‘13 Q1‘14 832 873 445 428 +5% -4% 1,277 1,301 +2% 343 -6% 953 946 -1% 610 321 Adj. EBITDA* Adj. EBIT* 625 +2% • Q1 2014 Investor Conference Call • Marijn Dekkers
    • Sales Earnings Q1 2014 – CropScience: Early Start to the Season in Europe Page 8 Crop Protection +6% (+12%) Environmental Science +1% (+8%) Seeds +3% (+12%) In € million, ∆% yoy, () = Fx & portf. adjusted CropScience €2,900m; +5% (+12%) Price +2% Volume +10% Fx -7% Portfolio 0% 2,231 Q1‘13 Q1‘14 Q1‘13 Q1‘14 1,081 1,098 +2% 969 988 +2% Adj. EBITDA* Adj. EBIT* 166 503 • Q1 2014 Investor Conference Call • Marijn Dekkers *before special items
    • Sales Earnings Q1 2014 – MaterialScience: Demand Led Growth Page 9 **CAS: Coatings, Adhesives, Specialties *** IO: Industrial Operations CAS** 0% (+7%) In € million, ∆% yoy, () = Fx & portf. adjusted *before special items MaterialScience €2,803m; +1% (+5%) Price -3% Volume +8% Fx -3% Portfolio -1% 1,510659 IO*** -6% (-5%) Q1‘13 Q1‘14 Q1‘13 Q1‘14 Adj. EBITDA* Adj. EBIT* 204 366 +79% 43 221 469 165 • Q1 2014 Investor Conference Call • Marijn Dekkers Polyurethanes +3% (+6%) Polycarbonates -1% (+2%) >100%
    • Q1 2014 – Full-Year Group Guidance Maintained Page 10 2013 2014E* Sales €40.2bn ~5% to ~€41-42bn (neg. FX effect approx. -2%) adj. EBITDA €8.4bn low- to mid-single- digit % increase (neg. FX effect approx. -5%) core EPS €5.61 mid-single-digit % increase (neg. FX effect approx. -6%) Sales ∆ Fx and portfolio adjusted, EBITDA before special items *Assuming average Fx rates of Q4’13 (USD 1.36) Outlook depends on specific planning assumptions as detailed in the Annual Report• Q1 2014 Investor Conference Call • Marijn Dekkers
    • Investor Conference Call Q1 2014 Results April 28, 2014 / Marijn Dekkers, CEO • Q1 2014 Investor Conference Call • Marijn DekkersPage 11